May Wang
Corporate Officer/Principal bei HUTCHMED (CHINA) LIMITED
Aktive Positionen von May Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HUTCHMED (CHINA) LIMITED | Corporate Officer/Principal | 01.01.2010 | - |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 27.07.2011 | - |
Karriereverlauf von May Wang
Ehemalige bekannte Positionen von May Wang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Ausbildung von May Wang
| Purdue University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| China | 2 |
| Hong Kong | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
